Pexacerfont

Pexacerfont (BMS-562086) is a potent and orally active CRF-1 antagonist. Pexacerfont is a recently developed CRF-1 antagonist which is currently in clinical trials for the treatment of anxiety disorders, and has also been proposed to be useful for the treatment of depression and irritable bowel syndrome. BMS-562086 exhibited favorable ADME and pharmacokinetic properties for further development.


Cat. No.: EX-A3079	Purity: >98%

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock
25mg	385	In-stock
50mg	550	In-stock
100mg	750	In-stock
200mg	1250	In-stock
500mg	1950	In-stock

Send PO to E-mail:order@excenen.com; or Fax:+86 020 81619670

Discount Request


Synonyms	BMS-562086
CAS No.	459856-18-9
Purity	>98%
Formula	C18H24N6O
Mol Weight	340.4228
Appearance	solid powder
Solubility	Soluble in DMSO
Shelf Life	>2 years if stored properly
Storage	Powder -20℃ 2 years; In solvent -20℃ 1 month;
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1]. Zhou L, et al. In vitro and in vivo metabolism and pharmacokinetics of BMS-562086, a potent and orally bioavailable corticotropin-releasing factor-1 receptor antagonist. Drug Metab Dispos. 2012 Jun;40(6):1093-103.
CoA	CoA of Pexacerfont

Smiles:	CC[C@H](NC1=NC(C)=NC2=C(C3=CC=C(OC)N=C3C)C(C)=NN21)C


		Search